-
Exo1 for Mechanistic Exocytosis Assays
2026-08-28
Exo1, also known as methyl 2-(4-fluorobenzamido)benzoate, enables rapid dissection of Golgi–ER trafficking and ARF1-dependent secretion. This article explains how to use it as a mechanistic perturbation while avoiding the common mistake of treating broad secretory blockade as selective tumor extracellular vesicle inhibition.
-
Candida EVs, Nrg1, and Candidemia
2026-08-28
The reference study identifies a concentration-dependent self-inhibitory role for Candida albicans extracellular vesicles, linking EV exposure to SKO1-dependent induction of the hyphal repressor NRG1. Genetic and mouse infection experiments connect this transcriptional circuit with reduced hyphal development, improved survival, and lower fungal burden, while also defining important limits for therapeutic interpretation.
-
Proteinase K: From DNA Prep to Translational Insight
2026-08-27
Proteinase K is more than a routine digestion reagent. This thought-leadership guide explains how its broad-spectrum serine protease activity supports high-integrity DNA workflows, enables mechanistic studies of protein cargo, and can strengthen translational investigations inspired by recent Candida albicans extracellular-vesicle research.
-
Chondrocyte-Targeted NAC Nanoparticles in Osteoarthritis
2026-08-27
This 2025 Small Science study develops chondroitin sulfate-modified PLGA nanoparticles for sustained, chondrocyte-targeted delivery of N-acetylcysteine in osteoarthritis. The formulation preserves glutathione and GPX4 activity, suppresses ferroptosis under mechanical stress, and protects cartilage more effectively than free NAC or nontargeted nanoparticles in a murine model.
-
Dabigatran Etexilate: Translational Thrombin Strategy
2026-08-26
A mechanistic and translational guide to using Dabigatran etexilate as a direct thrombin inhibitor, from target engagement and coagulation assays to atrial fibrillation research and in vivo validation.
-
METTL16–SENP3–LTF Drives HCC Ferroptosis Resistance
2026-08-26
Wang et al. identify a METTL16–SENP3–LTF signaling axis that suppresses iron-dependent lipid peroxidation and promotes hepatocellular carcinoma progression. By combining epitranscriptomic, protein-turnover, genetic, organoid, animal, and clinical analyses, the study connects m6A-regulated RNA stability with iron sequestration and suggests a route for ferroptosis sensitization.
-
Stiripentol: Applied LDH Inhibitor Workflows
2026-08-25
Stiripentol offers a research-ready route to perturb LDH1/LDH5-dependent lactate flux in epilepsy, metabolic, and immune-cell assays. This guide turns its mechanism and solubility profile into practical workflows for astrocyte-neuron lactate shuttle studies, lactate measurements, and histone lactylation experiments.
-
CKI 7 dihydrochloride: Reliable CK1 Assays
2026-08-25
This scenario-driven guide explains how CKI 7 dihydrochloride, SKU B4936, can support controlled Casein kinase 1 inhibition studies in viability, proliferation, apoptosis, Wnt, circadian, and cancer biology workflows. It covers experimental controls, solution preparation, interpretation, and practical product-selection criteria without overstating evidence.
-
Reserpine (N1867): Practical Lab Workflow
2026-08-24
Reserpine (SKU N1867) provides a defined, high-purity research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers identity checks, DMSO preparation, storage, and assay controls; the material is for research use only and is not intended for diagnostic, clinical, or veterinary applications.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding
2026-08-24
The reference study shows that naturally occurring angiotensin peptides can enhance SARS-CoV-2 spike protein binding to host receptors, with effects determined by peptide length, receptor identity, and tyrosine modification. Its antibody-based binding experiments identify angiotensin (2–7) and related fragments as useful probes for investigating how renin-angiotensin signaling intersects with viral receptor engagement, while also highlighting important limits on biological interpretation.
-
Brefeldin A: From Trafficking Block to ER Stress
2026-08-23
Brefeldin A is more than a vesicle transport inhibitor: it is a temporal perturbation tool for connecting ER-to-Golgi traffic, protein quality control, and cancer-cell fate. This guide explains how to design and interpret BFA experiments using ER-stress adaptation as the central decision point.
-
Merbromin as a Mixed-Type SARS-CoV-2 3CLpro Inhibitor
2026-08-22
The reference study identified Merbromin as a selective mixed-type inhibitor of the SARS-CoV-2 3CLpro protease through activity-based screening, enzyme kinetics, binding analysis, and molecular docking. Its findings provide a biochemical starting point for inhibitor design while emphasizing the difference between target-level inhibition and demonstrated antiviral efficacy.
-
SINE-Induced XPO1 Degradation by Allostery
2026-08-22
The reference study shows that SINE inhibitors do more than block XPO1-mediated nuclear export: they remodel XPO1 to recruit the CRL substrate receptor ASB8 and trigger ubiquitin-dependent degradation. Cryo-EM, cellular turnover assays, and mechanistic validation define an allosteric degradation pathway that may explain how synthetic XPO1 inhibitors exploit a native cellular response.
-
Phosbind Biotin for Reliable Phosphorylation Analysis
2026-08-21
Phos binding reagent (Phosbind) Biotin, SKU F4001, supports sequence-independent Western Blot detection of phosphorylated proteins through dinuclear metal complex phosphate binding. This scenario-driven guide explains assay compatibility, reagent handling, interpretation, and practical vendor-selection considerations for researchers studying viability, proliferation, cytotoxicity, and signaling.
-
Microsecond Pulsed Fields and Mitochondrial Cardiac Ablation
2026-08-20
The reference study defines exposure conditions under which microsecond pulsed electric fields produce reliable cardiomyocyte ablation and links the effect to mitochondrial disruption and apoptosis-associated signaling. Its combination of dose-response testing, transcriptomics, ultrastructural imaging, and mouse validation provides a mechanistic framework for interpreting pulsed-field ablation beyond irreversible electroporation alone.